Track market-moving stories before they get noisy

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of the company’s senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws.

If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

Key Details of the Ensign ($ENSG) Class Action:

Lead Plaintiff Deadline: December 7, 2026Alleged Misconduct: Securities fraud alleging Ensign misrepresented that its business model relied on patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme.Largest Alleged Stock Drop: June 8, 2026 – 8.15%Court: U.S. District Court for the Central District of CaliforniaAction: Contact BFA Law to discuss your rights Investors have until December 7, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ensign securities. The class action is pending in the U.S. District Court for the Central District of California. It is captioned Perusek v. The Ensign Group, Inc., et al., No. 8:26-cv-02963.

Why is Ensign Being Sued for Securities Fraud?

Ensign is a healthcare services company that operates skilled nursing, senior living, and rehabilitative care facilities through affiliated providers. The company relies heavily on Medicare and Medicaid reimbursements, making patient care, staffing, billing, and regulatory compliance central to its business model.

According to the complaint, Ensign represented that quality patient care was central to its business, described its clinical outcomes and CMS ratings, and characterized regulatory and compliance risks as contingencies.

As alleged, Defendants concealed systematic understaffing and patient neglect, manipulated reported quality and staffing data, engaged in improper Medicare and Medicaid billing and upcoding, and used licensed administrators who did not actually manage certain facilities.

Why did Ensign’s Stock Drop?

On June 8, 2026, Hunterbrook Media published “Ensign: The Nursing Home Empire Built on Fatal Neglect,” based on a five-month investigation. The report alleged that Ensign acquired distressed nursing facilities, reduced registered-nurse and other skilled-care hours, used self-reported data to improve quality ratings, and generated profits by providing less care than residents required despite receiving public funds based on patient acuity.

On this news, the price of Ensign stock fell $13.88 per share, or 8.15%, from a closing price of $170.30 per share on June 5, 2026, to $156.42 per share on June 8, 2026.

On June 11, 2026, Muddy Waters Research published “Ensign: Deceiving the Government at Estimated ~20% of Facilities.” The report alleged that Ensign used licensed administrators who were seldom present and did not actually manage certain facilities, while unlicensed operators handled day-to-day operations. Muddy Waters estimated that the alleged practices existed at approximately 20% of Ensign’s skilled nursing facilities and could expose Ensign to significant sanctions, slower growth, and reduced margins.

On this news, the price of Ensign stock fell $4.52 per share, or 2.98%, from a closing price of $151.65 per share on June 10, 2026, to $147.13 per share on June 11, 2026.

On June 18, 2026, Hunterbrook published a follow-up report, “New: Patients Hungry in Ensign Facilities,” alleging additional firsthand evidence of resident hunger, inadequate food and supplies, payroll and staffing-data falsification, understaffing, and employees working above their license levels.

On this news, the price of Ensign stock fell $2.19 per share, or 1.4%, to close at $153.65 per share on June 18, 2026.

Click here for more information: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

What Can You Do?

If you invested in Ensign, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/ensign-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360, and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.”  One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/ensign-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

New York, New York--(Newsfile Corp. - October 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2026 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Ensign securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Ensign class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Ensign's business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care; (2) Ensign's abuse and neglect includes not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (3) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (4) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients; (5) Ensign falsifies the number of hours that Certified Nursing Assistants spend with residents; (6) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; (7) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model; and (8) as a result, defendants' statements about Ensign's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ensign class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319514

Source: The Rosen Law Firm PA

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK and NEW ORLEANS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in The Ensign Group, Inc. (NasdaqGS: ENSG) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired The Ensign Group, Inc. securities between February 10, 2022 and June 18, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-ensg/   

Ensign investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ensg/ to learn more.

>>>CLICK HERE for more information

CASE DETAILS: According to the Complaint, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

Specifically, the lawsuit alleges that Defendants failed to disclose to investors that: (i) Ensign’s business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care; (ii) Ensign’s abuse and neglect includes not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (iii) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (iv) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients; (v) Ensign falsifies the number of hours that Certified Nursing Assistants spend with residents; (vi) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; and (vii) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model.

The case is Perusek v. The Ensign Group, Inc., No. 26-cv-02963.

WHAT TO DO? If you invested in Ensign and suffered a loss during the relevant time frame, you have until December 7, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of The Ensign Group, Inc. Investors -- ENSG Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Ensign investors under the federal securities laws.

To join the Ensign class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Ensign’s business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care; (2) Ensign’s abuse and neglect includes not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (3) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (4) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients; (5) Ensign falsifies the number of hours that Certified Nursing Assistants spend with residents; (6) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; (7) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model; and (8) as a result, defendants’ statements about Ensign’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured billions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008026527/en/

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

 | Source: The Ensign Group, Inc.

SAN JUAN CAPISTRANO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of four facilities in Washington (i) “Burien Nursing and Rehabilitation”, a 140-bed skilled nursing facility located in Burien, WA; (ii) “Issaquah Nursing and Rehabilitation”, a 140-bed skilled nursing facility located in Issaquah, WA; (iii) “Park Ridge Nursing and Rehabilitation”, a 115-bed skilled nursing located in Shoreline, WA; and (iv) “Park West Nursing and Rehabilitation”, a 137-bed skilled nursing facility located in Seattle, WA. Each of these facilities is operated by an Ensign affiliated operator and is subject to a long-term triple net lease.

“The addition of these facilities represents an exciting opportunity to strengthen our presence in the Pacific Northwest and further expand our operations in Washington,” said Barry Port, Ensign’s Chief Executive Officer. “These facilities serve vibrant communities throughout the Seattle area, and we have tremendous confidence in our local leadership teams and their ability to support strong clinical programs while maintaining a resident-centered approach to care.”

Steve Farnsworth, President of Pennant Healthcare LLC, Ensign’s Washington-based subsidiary, added “These facilities have long served as important healthcare resources in their communities, and we are excited to build upon that legacy. Our local teams look forward to working closely with these amazing caregivers as we continue enhancing care for the residents and families in these communities.”

In an additional transaction on the same day, Ensign announced that it acquired the operations of eight facilities in Florida comprised of 713 additional skilled nursing beds and 66 independent living units. Every facility is operated by an Ensign affiliated operator and is subject to a long-term triple net lease.

In a separate transaction on the same day, Ensign announced that it acquired the real estate and operations of “Englewood Heights Nursing and Rehabilitation”, a 118-bed skilled nursing facility located in Pensacola, Florida. The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and the facility is operated by an Ensign-affiliated tenant.

In another transaction on the same day, Ensign announced that it acquired the operations of seven facilities in Colorado comprised of 760 additional skilled nursing beds and 47 independent living units. All seven facilities are operated by an Ensign affiliated operator and are subject to a long-term triple net lease.

Additionally, Ensign announced that through subsidiaries of Standard Bearer Healthcare REIT, Inc. it acquired the real estate assets to five facilities that it had previously been operating under third-party triple net leases. These facilities total 755 skilled nursing beds and are now subject to long-term leases with subsidiaries of Standard Bearer.

As of today, Ensign's growing portfolio consists of 418 healthcare operations, which includes 50 senior living operations, across 18 states. Ensign subsidiaries, including Standard Bearer, own 189 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.

About EnsignTM

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 418 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Florida, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

 | Source: The Ensign Group, Inc.

SAN JUAN CAPISTRANO, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before October 31, 2026, to shareholders of record as of September 30, 2026.

Ensign has been a dividend-paying company since 2002.

About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 398 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

HighTower Advisors LLC trimmed its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 62.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,420 shares of the company’s stock after selling 17,274 shares during the period. HighTower Advisors LLC’s holdings in The Ensign Group were worth $1,670,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Transamerica Financial Advisors LLC purchased a new stake in The Ensign Group during the second quarter worth about $26,000. Monetary Solutions Ltd bought a new position in shares of The Ensign Group during the 4th quarter valued at approximately $30,000. Northwestern Mutual Wealth Management Co. grew its position in shares of The Ensign Group by 55.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock valued at $30,000 after acquiring an additional 61 shares during the period. Bayban purchased a new stake in shares of The Ensign Group during the 4th quarter worth approximately $31,000. Finally, Caitlin John LLC purchased a new stake in shares of The Ensign Group during the 2nd quarter worth approximately $31,000. 96.12% of the stock is owned by hedge funds and other institutional investors.

The Ensign Group Price Performance Shares of NASDAQ:ENSG opened at $173.98 on Monday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $10.14 billion, a PE ratio of 27.27, a P/E/G ratio of 1.65 and a beta of 0.69. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The company has a 50-day moving average price of $175.25 and a two-hundred day moving average price of $181.38.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last posted its earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.80 by $0.12. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The company’s revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the company earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities analysts forecast that The Ensign Group, Inc. will post 7.04 EPS for the current year. The Ensign Group Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Tuesday, June 30th. The Ensign Group’s payout ratio is currently 4.08%.

Insider Transactions at The Ensign Group In other The Ensign Group news, Director John Agwunobi sold 392 shares of the stock in a transaction on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the sale, the director owned 9,503 shares in the company, valued at $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth A number of equities research analysts recently commented on the stock. Truist Financial lifted their price target on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a report on Thursday, July 30th. Royal Bank Of Canada reissued an “outperform” rating and set a $228.00 price objective on shares of The Ensign Group in a report on Tuesday, July 28th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Finally, Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $216.25.

Check Out Our Latest Report on The Ensign Group

The Ensign Group Company Profile (Free Report)

The Ensign Group, Inc (NASDAQ: ENSG) is a healthcare services company that provides post-acute and senior care through a network of independently operated subsidiaries. Its businesses primarily focus on skilled nursing, rehabilitation and transitional care for patients recovering from illness, injury or surgery, as well as long-term care for seniors and individuals with complex medical needs.

The company also operates or supports assisted living, independent living, memory care, home health and hospice services in selected markets.

See Also Five stocks we like better than The Ensign Group Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound 3 Small-Cap Biotechs With Binary Catalysts on the Calendar Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.

Canada Pension Plan Investment Board purchased a new position in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,400 shares of the company’s stock, valued at approximately $1,507,000.

Other institutional investors have also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after acquiring an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in shares of The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after purchasing an additional 213 shares in the last quarter. Amundi lifted its position in shares of The Ensign Group by 480,216.7% during the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after purchasing an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. lifted its position in shares of The Ensign Group by 26.1% during the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after purchasing an additional 421 shares during the last quarter. 96.12% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets Several analysts recently weighed in on ENSG shares. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a report on Tuesday, July 28th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Truist Financial upped their price target on The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. Finally, Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, The Ensign Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $216.25.

View Our Latest Analysis on ENSG The Ensign Group Price Performance Shares of NASDAQ:ENSG opened at $172.26 on Tuesday. The firm’s 50 day moving average is $173.71 and its two-hundred day moving average is $183.89. The firm has a market capitalization of $10.04 billion, a P/E ratio of 27.00, a PEG ratio of 1.66 and a beta of 0.68. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06. The Ensign Group, Inc. has a 52 week low of $141.58 and a 52 week high of $218.00.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last issued its quarterly earnings data on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same period in the previous year, the business earned $1.59 earnings per share. The company’s revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts anticipate that The Ensign Group, Inc. will post 6.93 earnings per share for the current year.

The Ensign Group Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were issued a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is presently 4.08%.

Insiders Place Their Bets In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction that occurred on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the transaction, the director owned 9,503 shares in the company, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company’s stock.

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Read More Five stocks we like better than The Ensign Group Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season Insiders Are Betting Big on These 3 Healthcare Stocks 3 Stocks for Investors Who Still Believe Cash Is King Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG – Free Report).

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Ensign Group is benefiting from rising occupancy, patient volumes and skilled-mix revenue growth.Ensign Group completed 25 acquisitions in H1 2026, adding 3,109 beds and units.Standard Bearer's rental revenues rose to $44.1 million, adding recurring income to Ensign's strategy. The Ensign Group, Inc. (ENSG - Free Report) remains well positioned to benefit from favorable demographic trends and continued demand for post-acute care, supported by rising occupancy, patient volumes and skilled mix. The company provides post-acute healthcare services primarily through its Skilled Services and Standard Bearer segments, with operations spanning skilled nursing, senior living, rehabilitation and related healthcare services.

Following a steady pace of acquisitions, Ensign's footprint now comprises 398 healthcare operations, 32 of which also offer senior living services across 17 states. The company owns 183 healthcare real estate properties, of which 144 are operated by Ensign-affiliated entities. Since 2024, Ensign has sourced, underwritten, closed and transitioned 102 new operations. ENSG has risen 3.7% year to date compared with the industry’s average gain of 5%. ENSG currently carries a Zacks Rank #2 (Buy).

Where Do Estimates for ENSG Stand?The Zacks Consensus Estimate for Ensign Group’s 2026 earnings is pegged at $7.65 per share, indicating a 16.4% year-over-year rise. The consensus mark for revenues is pegged at $5.88 billion for 2026, implying 16.3% year-over-year growth. ENSG beat earnings estimates in each of the past four quarters, delivering an average surprise of 4.2%.

The Ensign Group, Inc. Price, Consensus and EPS SurpriseENSG’s Growth DriversEnsign's exposure to the post-acute care market provides a favorable foundation for growth, as rising demand supports higher occupancy and patient volumes. It also has opportunities to improve transitioning facilities, where operational metrics remain below those of mature operations, leaving room for further revenue and profitability gains as these facilities mature. In the second quarter of 2026, same-facility occupancy reached 84.1%, while transitioning-facility occupancy was 84.7%. Skilled-mix revenues increased 10.1% and 14.0%, respectively, highlighting continued strength in demand and operational improvement.

Strategic acquisitions remain a key growth driver for Ensign, providing opportunities to expand its operating footprint and improve underperforming facilities through its established operating model. During the first half of 2026, the company completed 25 operational acquisitions, adding 3,109 beds and units, while spending approximately $412 million on acquisitions.ENSG expects to maintain a healthy pace of acquisition activity, with additional opportunities lined up for the second half of 2026. Reflecting continued operating momentum and the contribution from acquisitions, Ensign raised its 2026 adjusted EPS guidance to $7.75-$7.85, with the midpoint representing 18.7% growth over 2025.

Beyond its healthcare operations, Ensign continues to expand its real-estate platform through the Standard Bearer segment. As of the second quarter of 2026, Standard Bearer owned 177 properties with an estimated real estate fair value of approximately $2.2 billion, while 99% of its leases expire after 2031.Standard Bearer's contribution is also growing rapidly. Second-quarter rental revenues increased to $44.1 million from $31.5 million a year earlier, while segment income increased to $12.1 million from $9.1 million. Funds from Operations rose to $24.7 million from $18.4 million. The expansion of the real-estate portfolio therefore provides Ensign with an additional source of recurring rental income while supporting its broader post-acute care strategy.

Ensign's balance sheet continues to provide substantial financial flexibility for acquisitions and investment. As of June 30, 2026, the company had $262.3 million in cash and cash equivalents and approximately $591.6 million of availability under its credit facility. Operating activities generated $272.1 million of cash during the first six months of 2026, while long-term debt totaled $135.6 million, excluding $4.2 million of current maturities. The company's net debt-to-adjusted EBITDAR ratio was 2.02X, and management highlighted more than $850 million of dry powder available for future investments.

ENSG: Risks to WatchThere are some factors, however, that investors should keep an eye on.

Ensign remains exposed to reimbursement and regulatory risks due to its reliance on government-funded payers. Medicare and Medicaid accounted for 69.0% of service revenues in the first half of 2026, making reimbursement and policy changes important factors for profitability. Competition for acquisitions, labor and patient referrals also remains a key risk in the highly competitive and fragmented post-acute care market.

Cost pressures remain a key factor to watch. Total expenses increased 12.3% in 2024 and 18.7% in 2025, followed by an 18.0% year-over-year increase to $2.57 billion in the first half of 2026. If expense growth continues to outpace revenue gains, it could pressure margins and limit earnings growth.

Other Stocks to ConsiderSome other top-ranked stocks in the broader Medical space are Tenet Healthcare Corporation (THC - Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present, and The Pennant Group, Inc. (PNTG - Free Report) and PACS Group, Inc. (PACS - Free Report) , both carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Tenet Healthcare’s 2026 earnings is pegged at $20.60 per share, indicating a 22.8% year-over-year improvement. THC beat earnings estimates in each of the trailing four quarters, with the average surprise being 22.7%. The consensus estimate for 2026 revenues is pinned at $22.16 billion, implying 4% year-over-year growth.

The Zacks Consensus Estimate for Pennant Group’s 2026 earnings is pegged at $1.39 per share, indicating a 17.8% year-over-year improvement. It beat earnings estimates in each of the trailing four quarters, with the average surprise being 6.4%. PNTG has witnessed two upward revisions in the past 60 days, with no movement in the opposite direction.

The Zacks Consensus Estimate for PACS Group’s 2026 earnings is pegged at $2.36 per share, indicating 93.44% year-over-year growth. PACS has witnessed one upward revision in the past 60 days, with no movement in the opposite direction. The consensus estimate for 2026 revenues is pinned at $5.8 billion, implying 9.7% year-over-year growth.

B. Metzler seel. Sohn & Co. AG purchased a new stake in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 44,181 shares of the company’s stock, valued at approximately $7,082,000. B. Metzler seel. Sohn & Co. AG owned approximately 0.08% of The Ensign Group as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Private Trust Co. NA increased its holdings in shares of The Ensign Group by 156.5% during the 4th quarter. Private Trust Co. NA now owns 159 shares of the company’s stock worth $28,000 after buying an additional 97 shares during the last quarter. Monetary Solutions Ltd acquired a new position in shares of The Ensign Group in the fourth quarter valued at approximately $30,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of The Ensign Group by 55.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock worth $30,000 after acquiring an additional 61 shares during the period. Bayban purchased a new stake in The Ensign Group in the 4th quarter valued at approximately $31,000. Finally, Cedar Mountain Advisors LLC purchased a new position in The Ensign Group in the first quarter worth $32,000. Hedge funds and other institutional investors own 96.12% of the company’s stock.

Wall Street Analyst Weigh In Several brokerages recently issued reports on ENSG. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a report on Tuesday, July 28th. Finally, Truist Financial increased their price target on The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $216.25.

Get Our Latest Stock Report on The Ensign Group Insider Activity In other news, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the transaction, the director directly owned 9,503 shares of the company’s stock, valued at $1,625,583.18. This represents a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the transaction, the director owned 21,352 shares in the company, valued at $3,507,706.56. This trade represents a 3.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.00% of the company’s stock.

The Ensign Group Stock Performance Shares of ENSG opened at $179.48 on Friday. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The firm’s 50 day moving average price is $171.11 and its two-hundred day moving average price is $184.42. The firm has a market cap of $10.46 billion, a P/E ratio of 28.13, a PEG ratio of 1.73 and a beta of 0.68. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last released its quarterly earnings data on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The firm’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, analysts forecast that The Ensign Group, Inc. will post 6.93 EPS for the current fiscal year.

The Ensign Group Announces Dividend The company also recently announced a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were given a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

The Ensign Group Company Profile (Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Recommended Stories Five stocks we like better than The Ensign Group Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG – Free Report).

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.

On June 8, 2026, Hunterbrook Media published a report entitled "Ensign: The Nursing Home Empire Built On Fatal Neglect." The report alleges that "Ensign's business model relies on delivering inadequate care to patients while gaming data on quality, according to Hunterbrook's five-month investigation." The report further alleges "[f]ormer employees in different states described systematic misrepresentations."

Following this news, the price of Ensign stock fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this investigation, please contact:

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/the-ensign-group-inc-class-action-alert-learn-more-now/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/310129

Source: Kaplan Fox & Kilsheimer LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Ensign Energy Services TSE: ESI reported higher second-quarter revenue and adjusted EBITDA as operating activity increased across Canada, the United States and international markets, while the company continued to reduce debt and prepared to close its acquisition of Citadel Drilling Ltd.

Revenue for the second quarter of 2026 rose 7% year over year to C$397.3 million. Adjusted EBITDA increased 6% to C$85.8 million, compared with C$81.4 million in the prior-year quarter. For the first six months of 2026, revenue increased 1% to C$815.4 million, while adjusted EBITDA declined 2% to C$180.7 million.

Get Ensign Energy Services alerts:

CFO Trevor Russell said the quarterly EBITDA improvement primarily reflected higher operating activity, partly offset by the foreign-exchange impact of translating U.S.-dollar-denominated revenue. Operating days increased 7% in Canada to 2,667, 5% in the U.S. to 3,088 and 15% internationally to 1,246.

Debt Reduction and Capital Spending Ensign repaid C$30 million of debt during the quarter and C$37.37 million during the first six months of the year. Interest expense fell 13% year over year to C$16.1 million, which Russell attributed to lower debt, lower effective interest rates and foreign-exchange translation effects.

The company revised its 2026 debt-reduction target to net C$60 million from a previously announced C$125 million target. Russell said the revision reflects the planned Citadel acquisition and increased capital investment. He said Ensign expects liquidity to be in the low C$90 million range at the end of 2026 after the acquisition closes.

Net purchases of property and equipment totaled C$58.1 million in the quarter, including C$25.4 million in upgrade capital and C$41.4 million in maintenance capital, offset by C$8.7 million in asset-disposition proceeds. Ensign maintained its 2026 maintenance capital expenditure outlook at about C$162 million and projected selective upgrade spending of approximately C$95.8 million, including C$68.6 million that is customer funded.

Citadel Deal Expands Permian Presence President and COO Bob Geddes said the Citadel Drilling acquisition was expected to close the following week and would add six active 2,000-horsepower rigs to Ensign’s Permian fleet. He said the rigs were fully utilized but declined to provide further financial details prior to closing.

Geddes said the acquisition would increase Ensign’s presence in the Permian Basin to roughly 11%, from approximately 7% to 8% currently. The company had 41 rigs under contract in the U.S. at the time of the call, excluding the Citadel fleet, and expected to add approximately one rig per month through year-end. Including Citadel’s rigs, management indicated Ensign expected to add four additional U.S. rigs by year-end.

In the company’s U.S. operations, Ensign had five high-specification ADR rigs under contract in California, eight active rigs in the Rockies and 27 active rigs in its U.S. Southern division. Geddes said the Permian remained the company’s most active market, with demand supporting expectations for four to five additional rigs to begin work by year-end. Nearly half of the company’s U.S. rigs were operating under performance-based contracts, he said.

Canadian Activity, Pricing and International Operations Ensign had 51 rigs active in the Western Canadian Basin, up 17% from a year earlier. Geddes said all five rigs that underwent five-year recertifications during breakup had returned to work. Management expects to add several Canadian rigs by year-end and said some operators are seeking to secure high-specification ADR rigs into spring 2027 and beyond.

Geddes said Ensign was raising rates by C$1,000 per day per quarter as contracts move into the second half of 2026 and into 2027. More broadly, he said the company expects rates on contract renewals to rise roughly 5% to 10% amid tightening supplies of high-specification rigs, rising contractor costs and longer lead times for new equipment.

Internationally, Ensign’s fleet reached 27 rigs following the transfer of a high-specification ADR 1500 rig to Venezuela and commissioning of a fifth ADR rig in Oman. The company’s two rigs in Kuwait and two rigs in Bahrain were shut down amid the Middle East conflict, while all five Oman rigs remained active. Ensign expects one Bahrain rig to be recontracted before year-end and has submitted bids for its two Kuwait rigs, though potential Kuwait work would not begin until mid-2027.

Ensign had four rigs operating in Australia, with a fifth expected to start within 30 days. Its two ADR 2000 rigs in Argentina remained contracted into 2027. In Venezuela, Ensign had three rigs in the country and signed a contract for a fourth rig expected to arrive in early 2027. Geddes said all of the Venezuela rigs are under three-year contracts.

Contract Backlog and Automation Geddes said Ensign’s forward guaranteed contract book expanded 25%, bringing its long-term contracted revenue runway to C$1.4 billion. He said oilfield-service conditions remained supported by limited excess high-specification rig capacity, although producers continued to focus on cash flow and maintaining production.

The company’s Edge drilling-rig control platform was installed on 65% of Ensign’s rigs globally. Geddes said Ensign sees an opportunity to grow the automation business’s revenue and profit by 15% annually. Its directional drilling, trucking, rentals and managed-pressure-drilling businesses continued to generate steady revenue and margins with little or no capital required, he added.

About Ensign Energy Services (TSE:ESI)Ensign is a global leader in oilfield services, headquartered out of Calgary, Alberta, operating in Canada, the United States and internationally. We are one of the world's top land-based drilling and well servicing contractors serving crude oil, natural gas, and geothermal operators. Our premium services include contract drilling, directional drilling, underbalanced and managed pressure drilling, rental equipment and well servicing. Please visit our website at www.ensignenergy.com.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Ensign Energy Services Right Now?Before you consider Ensign Energy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ensign Energy Services wasn't on the list.

While Ensign Energy Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Raises 2026 Annual Earnings and Revenue Guidance;
Conference Call and Webcast scheduled for July 29, 2026 at 10:00 am PT

SAN JUAN CAPISTRANO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the second quarter ended June 30, 2026, reporting GAAP diluted earnings per share of $1.68 and adjusted earnings per share(1) of $1.92.

"This quarter's results are another reflection of that enduring connection between the commitment of our local leaders to delivering high-quality care in their communities and our financial performance. We believe exceptional outcomes ultimately create their own form of accountability, because residents, families, referral partners, regulators, and payers all independently validate whether an operation is truly delivering value,” said Barry Port, Chief Executive Officer of The Ensign Group. “We continue to see strong demand across our portfolio, improving occupancy and skilled mix. We also continue to grow in a disciplined way through acquisitions. We believe our results this quarter position us well for the remainder of the year and reinforce our confidence in our long-term strategy."

Clinical Highlights(1):

Same Facilities achieved Centers for Medicare & Medicaid Services (CMS) Quality Measure ratings that were 23% better than industry peers in our operating states, demonstrating superior clinical outcomes.Same Facilities achieved CMS Cycle 1 survey inspection results that were 18% better than industry peers in our operating states, validating clinical excellence through regulatory oversight.Over 80% of our skilled nursing operations earned a CMS Quality Measure rating of 4 or 5 stars, demonstrating our continued commitment to delivering high-quality clinical care.Rehospitalization rates for Same Facilities were 15% better than the national average, supporting successful resident recovery and continuity of care.Long-stay outpatient emergency department visit rates for Same Facilities were 24% better than the national average, minimizing unnecessary hospital transfers and reducing higher-cost care.Administrator turnover for Same Facilities was 46% lower than our industry peers in our operating states, supporting leadership continuity and operational stability.None of our 398 affiliated facilities are designated as CMS Special Focus Facilities, reflecting our ability to improve clinical performance at troubled acquisitions and consistently maintain trust from our state and federal regulators. Quarterly Highlights:

GAAP diluted earnings per share for the quarter was $1.68, an increase of 16.7% over the prior year quarter, and adjusted diluted earnings per share(2) for the quarter was $1.92, an increase of 20.8% over the prior year quarter.GAAP net income was $99.7 million for the quarter, an increase of 18.2% over the prior year quarter, and adjusted net income(2) was $114.3 million for the quarter, an increase of 22.5% over the prior year quarter.Same Facility and Transitioning Facility occupancy for the quarter were 84.1% and 84.7%, an increase of 2.7% and 2.3%, respectively, over the prior year quarter.Same Facility and Transitioning Facility skilled mix revenue for the quarter increased by 10.1% and 14.0%, respectively, and skilled days for the quarter increased by 6.2% and 9.4%, respectively, both over the prior year quarter.Same Facility and Transitioning Facility Medicare revenue for the quarter improved by 9.8% and 9.6%, respectively, and Medicare days for the quarter improved by 5.1% and 5.2%, respectively, both over the prior year quarter.Same Facility and Transitioning Facility managed care revenue for the quarter improved by 6.1% and 16.2%, respectively, and managed care days for the quarter improved by 1.9% and 7.6%, respectively, both over the prior year quarter.Same Facility and Transitioning Facility skilled services revenue for the quarter increased by 6.6% and 6.1% over the prior year quarter.Consolidated revenue for the quarter was $1.44 billion, an increase of 17.3% over the prior year quarter.Standard Bearer(3) revenue was $44.1 million for the quarter, an increase of 40.2% over the prior year quarter. FFO was $24.7 million for the quarter, an increase of 34.6% over the prior year quarter.
(1) The data source for clinical results is from CMS Care Compare Five-Star Quality Rating System, June 2026. Cycle 1 survey inspection results are based on the latest CMS-reported regulatory inspection cycle which reflects results as of Q4 2025. State-wide averages represent the average reported performance of facilities within the states in which we operate. National averages represent the average performance of all facilities included in the CMS Care Compare database nationwide.(2) See "Reconciliation of GAAP to Non-GAAP Financial Information".(3) Our Skilled Services and Standard Bearer Segments are defined and outlined in Note 7 on Form 10-Q.
Clinical and Operating Results

“The strength of our model ultimately depends on the quality and stability of our people. We have long believed that outstanding resident outcomes begin with engaged, supported, and empowered caregivers. We are especially proud of our turnover. In particular, our Director of Nursing turnover continues to improve and our overall RN retention rate is also 8% better than the average across our 17-state footprint using CMS reported data. Similarly, licensed administrator turnover is an impressive 46% lower than the CMS measured state average. We believe this level of leadership stability is one of the key differentiators of our organization by creating continuity for our caregivers and residents, reinforcing accountability at the local level, and allowing the investments we make in our clinical programs, technology, and resources to translate into consistently superior quality outcomes, care efficiency, regulatory performance, and financial results.”

He added, “On the census front, our Same Facility and Transitioning Facility occupancy for the second quarter was 84.1% and 84.7%, respectively. On the skilled mix front, our Same Facilities and Transitioning Facilities skilled revenue increased by 10.1% and 14.0%, respectively, over the prior year quarter. Medicare revenue increased for both our Same Facilities and Transitioning Facilities by 9.8% and 9.6%, respectively. Also, managed care revenue increased by 6.1% and 16.2%, respectively, for Same-Facilities and Transitioning Facilities over the prior year quarter, with total skilled mix days up 6.2% and 9.4%, respectively, from the prior year quarter. The primary driver of these improvements continues to be the expanding trust from the communities we serve—earned through consistent, high-quality clinical outcomes,” Port said.

“Due to the strength of the second quarter, we are increasing our annual 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from our previously increased guidance of $7.48 to $7.62. We are also increasing annual revenue guidance to $5.87 billion to $5.92 billion, up from $5.81 billion to $5.86 billion. The midpoint of our earnings guidance represents an 18.7% increase over 2025 and 41.8% over 2024," Port said.

Speaking to the Company’s acquisition growth, Chad Keetch, Ensign’s Chief Investment Officer and Executive Vice President said, “In addition, we continue to acquire new operations with significant long-term upside and expect to maintain a healthy pace of growth as we expand our mission driven approach to transform and dignify post-acute care. During the quarter and since we accelerated our growth by adding 20 new operations, all of which included real estate assets. Since 2024, we have successfully sourced, underwritten, closed, and transitioned 102 new operations across several markets, many of which are already performing at or above expectations, both clinically and financially. We continue to see opportunities that include everything from larger portfolios, landlords looking to replace current tenants, non-profits looking to divest of their post-acute assets and a steady flow of traditional one-sie two-sies. We have several new additions lining up for the second half of 2026 as our local leadership and their deal partners at the Service Center work together to source, underwrite and carefully select the right opportunities.”

Suzanne Snapper, Ensign’s Executive Vice President and Chief Financial Officer reported that the Company’s liquidity remains strong with approximately $262.3 million of cash on hand and $591.6 million of available capacity under its line-of-credit. Ms. Snapper also indicated that, “Management’s annual guidance is based on diluted weighted average common shares outstanding of approximately 59.5 million and a 25.0% tax rate. In addition, the guidance assumes, among other things, normalized insurance costs, acquisitions expected to close through the third quarter of 2026 and management’s current expectations regarding reimbursement rates. It also excludes certain charges that arise outside the normal course of business, amortization of system implementation costs, acquisition related costs and share-based compensation.”

A discussion of the Company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to adjusted EBT, EBITDA, adjusted EBITDAR, adjusted EBITDA and FFO for Standard Bearer, as well as a reconciliation of GAAP earnings per share, net income to adjusted net income and adjusted net earnings per share appear in the financial data portion of this release. More complete information is contained in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which is expected to be filed with the SEC today and can be viewed on the Company’s website at http://www.ensigngroup.net.

Growth and Real Estate Highlights

Mr. Keetch added additional commentary on the Company’s continued acquisition activity. “We were thrilled to complete these acquisitions, and to expand our presence in Texas. These assets are made up of newly constructed, high-quality facilities in populated and growing metro-areas. However, occupancies in these operations are almost all lower than our existing operations’ average for these geographies, and all present significant clinical and operational hurdles. These operations will take some time to establish a culture of ownership and accountability, but we are encouraged with the progress we have already seen and look forward to these new additions becoming the facility of choice in the markets they serve,” Keetch said.

Standard Bearer announced the following real estate acquisitions, which are operated by an Ensign-affiliate:

Willow Park Rehabilitation and Care Center, a 125-bed skilled nursing facility located in Willow Park, Texas;Southern Oaks Therapy and Living Center, a 150-bed skilled nursing facility located in Dallas, Texas;Country Village Care / Country Village Senior Living, a healthcare campus with 136 skilled nursing beds, 38 assisted living units, and 32 memory care beds located in Angleton, Texas;River Hills Health and Rehabilitation Center, a 150-bed skilled nursing facility located in Kerrville, Texas;Willow Creek Lodge, a 135-bed skilled nursing facility located in Tomball, Texas;Eagle Crest Rapid Recovery, a 125-bed skilled nursing facility located in Houston, Texas;Falcon Point Post Acute, a 130-bed skilled nursing facility located in Katy, Texas;Parks Health Center / Parks Assisted Living Center, a healthcare campus with 90 skilled nursing beds, 30 assisted living units, and 55 independent living units located in Odessa, Texas;La Dora Nursing and Rehabilitation Center, a 62-bed skilled nursing facility located in Bedford, Texas;River Bend Healthcare, a 115-bed skilled nursing facility located in Seguin, Texas;Mustang Park Therapy and Living Center, 120-bed skilled nursing facility located in Carrollton, Texas;Hilltop Village Nursing and Rehabilitation Center, 150-bed skilled nursing facility located in Kerrville, Texas;Mallard Creek Therapy and living Center, 120-bed skilled nursing facility located in Fort Worth, Texas;Harbor Valley Health and Rehabilitation, 120-bed skilled nursing facility located in San Antonio, Texas;TruCare Living Centers - Columbus, 104-bed skilled nursing facility located in Columbus, Texas;TruCare Living Centers - Palestine, 120-bed skilled nursing facility located in Palestine, Texas;TruCare Living Centers - Selma, 128-bed skilled nursing facility located in Selma, Texas;Woodland Health and Rehabilitation Care Center, 62-bed skilled nursing facility located in Mount Pleasant, Iowa;Las Ventanas de Socorro, a 126-bed skilled nursing facility located in Socorro, Texas; andLos Arcos del Norte Care Center, a 124-bed skilled nursing facility located in El Paso, Texas. Ensign's growing portfolio consists of 398 healthcare operations, 32 of which also include senior living operations, across 17 states. Ensign now owns 183 real estate assets, 144 of which are operated by an Ensign affiliate. Mr. Keetch noted that Ensign’s overall strategy will continue to include both leasing and acquiring real estate, and the Company is actively looking for performing and underperforming operations in several states.

In addition, the Company also acquired three senior living real estate assets that are operated by a third-party under a triple net lease:

Emerald Ridge of Neenah, a 45-unit residential care apartment complex located in Neenah, Wisconsin;Anna’s House Assisted Living, a 50-unit community based residential facility located in New Franken, Wisconsin; andMemory Care of Contra Costa, a 46-unit memory care facility located in Pleasant Hill, California. The Company continues to provide additional disclosure on Standard Bearer which is comprised of 177 owned properties. Of these assets, 140 are leased to an Ensign-affiliated operator and 38 are leased to third-party operators. Mr. Keetch noted that each of these properties are subject to triple-net, long-term leases and generated rental revenue of $44.1 million for the quarter, of which $37.8 million was derived from Ensign affiliated operations. For the quarter, Ensign reported $24.7 million in FFO.

The Company also paid a quarterly cash dividend of $0.065 per share of Ensign common stock. Ms. Snapper noted that as the Company’s liquidity remains strong, it plans to continue its long history of paying dividends into the future.

Conference Call

A live webcast will be held Wednesday, July 29, 2026, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) to discuss Ensign’s second quarter of 2026 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Ensign’s website at http://investor.ensigngroup.net. The webcast will be recorded and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, August 28, 2026.

About Ensign™

The Ensign Group, Inc.'s independent subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 398 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company will also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, emergency and non-emergency transportation services, long-term care pharmacy and other consulting services also across several states. Each of these operations is operated by a separate, independent subsidiary that has its own management, employees and assets. References herein to the consolidated "Company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center, Standard Bearer or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net. 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the Company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations continue to be impacted by the unprecedented nature of the changes in the regulations and environment, as such, we are unable to predict the full extent and duration of the financial impact of these changes on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and 10-K, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information
Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, [email protected]. 
SOURCE: The Ensign Group, Inc.

THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
 Three Months Ended June 30, Six Months Ended June 30,  2026   2025   2026   2025          (In thousands, except per share data)REVENUE       Service revenue$1,432,497  $1,221,414  $2,814,800  $2,388,454 Rental revenue 7,984   6,355   14,877   12,356 TOTAL REVENUE$1,440,481  $1,227,769  $2,829,677  $2,400,810 Expense:       Cost of services 1,134,237   971,780   2,230,063   1,899,629 Rent—cost of services 66,412   57,195   131,918   114,271 General and administrative expense 85,922   69,107   160,132   131,662 Depreciation and amortization 31,406   25,785   60,207   49,973 TOTAL EXPENSES$1,317,977  $1,123,867  $2,582,320  $2,195,535 Income from operations 122,504   103,902   247,357   205,275 Other income (expense):       Interest expense (1,933)  (2,025)  (3,865)  (4,062)Interest income 4,633   5,240   11,169   12,123 Other income 8,470   5,241   7,585   5,602 OTHER INCOME, NET$11,170  $8,456  $14,889  $13,663 Income before provision for income taxes 133,674   112,358   262,246   218,938 Provision for income taxes 33,840   27,892   62,656   54,119 NET INCOME$99,834  $84,466  $199,590  $164,819 Less: net income attributable to noncontrolling interests 96   70   184   146 NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.$99,738  $84,396  $199,406  $164,673         NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.       Basic$1.72  $1.48  $3.45  $2.88 Diluted$1.68  $1.44  $3.35  $2.81 WEIGHTED AVERAGE COMMON SHARES OUTSTANDING       Basic 57,958   57,157   57,865   57,128 Diluted 59,483   58,602   59,527   58,560  THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 June 30, 2026 December 31, 2025    ASSETS   Current assets:   Cash and cash equivalents$262,300 $503,881Accounts receivable—less allowance for doubtful accounts of $7,895 and $7,805 at June 30, 2026 and December 31, 2025, respectively 668,902  636,985Investments—current 58,544  68,506Prepaid expenses and other current assets 81,742  62,932Total current assets$1,071,488 $1,272,304Property and equipment, net 2,096,977  1,696,863Right-of-use assets 2,143,787  2,097,862Insurance subsidiary deposits and investments 210,077  166,841Deferred tax assets 83,068  83,138Restricted and other assets 39,755  41,600Intangible assets, net 6,263  6,381Goodwill 97,981  97,981TOTAL ASSETS$5,749,396 $5,462,970LIABILITIES AND EQUITY   Current liabilities:   Accounts payable$119,675 $97,327Accrued wages and related liabilities 368,817  422,326Lease liabilities—current 121,117  114,816Accrued self-insurance liabilities—current 100,007  81,623Other accrued liabilities 171,001  174,027Current maturities of long-term debt 4,182  4,227Total current liabilities$884,799 $894,346Long-term lease liabilities—less current portion 1,989,485  1,949,213Accrued self-insurance liabilities—less current portion 195,813  164,792Other long-term liabilities 98,428  82,266Long-term debt—less current maturities 135,562  137,529Total equity 2,445,309  2,234,824TOTAL LIABILITIES AND EQUITY$5,749,396 $5,462,970 THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
  The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
  Six Months Ended June 30,  2026   2025     NET CASH PROVIDED BY (USED IN): Operating activities$272,108  $227,950 Investing activities (478,893)  (311,924)Financing activities (34,796)  (16,655)Net decrease in cash and cash equivalents$(241,581) $(100,629)Cash and cash equivalents beginning of period 503,881   464,598 Cash and cash equivalents at end of period$262,300  $363,969  THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME

The following table reconciles net income to Adjusted net income and diluted earnings per share to Adjusted earnings per share for the periods presented:

 Three Months Ended June 30, Six Months Ended June 30,  2026   2025   2026   2025 Net income attributable to The Ensign Group, Inc.$99,738  $84,396  $199,406  $164,673 Adjustments:       Stock-based compensation expense(1) 16,166   11,662   30,061   22,386 Cost of services - loss (gain) on long-lived assets and business interruption recoveries —   (1,000)  1,284   (1,000)Cost of services - acquisition related costs(2) 519   654   800   1,135 General and administrative - costs incurred related to system implementations 2,180   437   5,199   771 Depreciation and amortization - patient base(3) —   409   —   1,020 Provision for income taxes on Non-GAAP adjustments(4) (4,295)  (3,238)  (12,242)  (6,693)Adjusted Net Income$114,308  $93,320  $224,508  $182,292         Average number of diluted shares outstanding 59,483   58,602   59,527   58,560         Diluted Earnings Per Share$1.68  $1.44  $3.35  $2.81         Adjusted Earnings Per Share$1.92  $1.59  $3.77  $3.11         Footnotes:       (1) Represents stock-based compensation expense incurred.     Three Months Ended June 30, Six Months Ended June 30,  2026   2025   2026   2025 Cost of services$10,723  $7,874  $19,893  $15,033 General and administrative 5,443   3,788   10,168   7,353 Total Non-GAAP adjustment$16,166  $11,662  $30,061  $22,386         (2) Represents costs incurred to acquire operations that are not capitalizable.(3) Represents amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.(4) Represents an adjustment to the provision for income tax to our historical effective tax rate of 25.0% THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)

The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:

 Three Months Ended June 30, Six Months Ended June 30, 2026  2025   2026  2025 Consolidated Statements of Income Data:       Net income$99,834 $84,466  $199,590 $164,819 Less: Net income attributable to noncontrolling interests 96  70   184  146 Interest income 4,633  5,240   11,169  12,123 Add: Provision for income taxes 33,840  27,892   62,656  54,119 Depreciation and amortization 31,406  25,785   60,207  49,973 Interest expense 1,933  2,025   3,865  4,062 EBITDA$162,284 $134,858  $314,965 $260,704 Adjustments to EBITDA:       Stock-based compensation expense 16,166  11,662   30,061  22,386 Costs incurred related to system implementations 2,180  437   5,199  771 Loss (gain) on long-lived assets and business interruption recoveries —  (1,000)  1,284  (1,000)Acquisition related costs(1) 519  654   800  1,135 ADJUSTED EBITDA$181,149 $146,611  $352,309 $283,996 Rent—cost of services 66,412  57,195   131,918  114,271 ADJUSTED EBITDAR$247,561   $484,227   (1) Represents costs incurred to acquire operations that are not capitalizable.

The table below reconciles income before provision for income taxes to Adjusted EBT for the periods presented:

 Three Months Ended June 30, Six Months Ended June 30, 2026  2025   2026  2025 Consolidated statements of income data:(In thousands)Income before provision for income taxes$133,674 $112,358  $262,246 $218,938 Stock-based compensation expense 16,166  11,662   30,061  22,386 Costs incurred related to system implementations 2,180  437   5,199  771 Loss (gain) on long-lived assets and business interruption recoveries —  (1,000)  1,284  (1,000)Acquisition related costs(1) 519  654   800  1,135 Depreciation and amortization - patient base(2) —  409   —  1,020 ADJUSTED EBT$152,539 $124,520  $299,590 $243,250  (1) Represents costs incurred to acquire operations that are not capitalizable.
(2) Represents amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.

THE ENSIGN GROUP, INC.
UNAUDITED SELECT PERFORMANCE INDICATORS

The following tables summarize our selected performance indicators for our skilled services segment along with other statistics, for each of the dates or periods presented:

 Three Months Ended June 30, 2026
 2025
 Change % Change        TOTAL FACILITY RESULTS:(Dollars in thousands)Skilled services revenue$1,379,912  $1,173,576  $206,336  17.6%Number of facilities at period end 348   304   44  14.5%Number of campuses at period end(1) 32   30   2  6.7%Actual patient days 3,017,641   2,615,490   402,151  15.4%Occupancy percentage — Operational beds 82.9%  81.3%  1.6% 2.0%Skilled mix by nursing days 31.0%  30.8%  0.2% 0.6%Skilled mix by nursing revenue 50.0%  49.2%  0.8% 1.6%  Three Months Ended June 30,  2026   2025  Change % Change        SAME FACILITY RESULTS:(2)(Dollars in thousands)Skilled services revenue$988,337  $926,850  $61,487  6.6%Number of facilities at period end 234   234   —  —%Number of campuses at period end(1) 25   25   —  —%Actual patient days 2,164,347   2,091,332   73,015  3.5%Occupancy percentage — Operational beds 84.1%  81.9%  2.2% 2.7%Skilled mix by nursing days 32.2%  31.3%  0.9% 2.9%Skilled mix by nursing revenue 51.0%  50.1%  0.9% 1.8%  Three Months Ended June 30,  2026   2025  Change % Change        TRANSITIONING FACILITY RESULTS:(3)(Dollars in thousands)Skilled services revenue$197,371  $185,981  $11,390  6.1%Number of facilities at period end 50   50   —  —%Number of campuses at period end(1) 4   4   —  —%Actual patient days 405,468   393,063   12,405  3.2%Occupancy percentage — Operational beds 84.7%  82.8%  1.9% 2.3%Skilled mix by nursing days 29.7%  28.0%  1.7% 6.1%Skilled mix by nursing revenue 49.7%  47.0%  2.7% 5.7%  Three Months Ended June 30,  2026   2025  Change % Change        RECENTLY ACQUIRED FACILITY RESULTS:(4)(Dollars in thousands)Skilled services revenue$194,204  $60,745  $133,459 NMNumber of facilities at period end 64   20   44 NMNumber of campuses at period end(1) 3   1   2 NMActual patient days 447,826   131,095   316,731 NMOccupancy percentage — Operational beds 76.6%  69.9% NM NMSkilled mix by nursing days 26.9%  30.4% NM NMSkilled mix by nursing revenue 45.1%  43.0% NM NM (1) Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment.(2) Same Facility results represent all facilities acquired prior to January 1, 2023.(3) Transitioning Facility results represent all facilities acquired from January 1, 2023 to December 31, 2024.(4) Recently Acquired Facility results represent all facilities acquired on or subsequent to January 1, 2025.  Six Months Ended June 30,  2026   2025  Change % Change        TOTAL FACILITY RESULTS:(Dollars in thousands)Skilled services revenue$2,710,747  $2,297,130  $413,617  18.0%Number of facilities at period end 348   304   44  14.5%Number of campuses at period end(1) 32   30   2  6.7%Actual patient days 5,913,675   5,153,626   760,049  14.7%Occupancy percentage — Operational beds 83.4%  81.6%  1.8% 2.2%Skilled mix by nursing days 31.5%  31.1%  0.4% 1.3%Skilled mix by nursing revenue 50.3%  49.7%  0.6% 1.2%  Six Months Ended June 30,  2026   2025  Change % Change        SAME FACILITY RESULTS:(2)(Dollars in thousands)Skilled services revenue$1,967,545  $1,843,338  $124,207  6.7%Number of facilities at period end 234   234   —  —%Number of campuses at period end(1) 25   25   —  —%Actual patient days 4,309,728   4,170,184   139,544  3.3%Occupancy percentage — Operational beds 84.2%  82.1%  2.1% 2.6%Skilled mix by nursing days 32.4%  31.8%  0.6% 1.9%Skilled mix by nursing revenue 51.1%  50.6%  0.5% 1.0%  Six Months Ended June 30,  2026   2025  Change % Change        TRANSITIONING FACILITY RESULTS:(3)(Dollars in thousands)Skilled services revenue$392,857  $364,903  $27,954  7.7%Number of facilities at period end 50   50   —  —%Number of campuses at period end(1) 4   4   —  —%Actual patient days 807,732   778,169   29,563  3.8%Occupancy percentage — Operational beds 84.9%  82.4%  2.5% 3.0%Skilled mix by nursing days 29.9%  28.4%  1.5% 5.3%Skilled mix by nursing revenue 49.7%  47.6%  2.1% 4.4%  Six Months Ended June 30,  2026   2025  Change % Change        RECENTLY ACQUIRED FACILITY RESULTS:(4)(Dollars in thousands)Skilled services revenue$350,345  $88,889  $261,456 NMNumber of facilities at period end 64   20   44 NMNumber of campuses at period end(1) 3   1   2 NMActual patient days 796,215   205,273   590,942 NMOccupancy percentage — Operational beds 78.3%  70.0% NM NMSkilled mix by nursing days 28.5%  27.7% NM NMSkilled mix by nursing revenue 46.8%  39.9% NM NM Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment.Same Facility results represent all facilities acquired prior to January 1, 2023.Transitioning Facility results represent all facilities acquired from January 1, 2023 to December 31, 2024.Recently Acquired Facility results represent all facilities acquired on or subsequent to January 1, 2025. THE ENSIGN GROUP, INC.
UNAUDITED SKILLED NURSING AVERAGE DAILY REVENUE RATES AND
PERCENT OF SKILLED NURSING REVENUE AND DAYS BY PAYOR

The following tables reflect the change in skilled nursing average daily revenue rates, excluding services that are not covered by the daily rate(1):

 Three Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026 2025 2026 2025 2026 2025 2026 2025SKILLED NURSING AVERAGE DAILY REVENUE RATESMedicare$814.66 $779.77 $890.48 $854.83 $784.73 $701.40 $822.24 $789.43Managed care 599.06  575.29  658.87  609.88  630.25  555.77  609.07  578.40Other skilled 649.37  647.61  678.38  685.81  683.77  711.96  655.51  655.04Total skilled revenue 685.04  661.18  776.70  745.39  713.52  652.03  700.39  672.15Medicaid 310.64  302.36  326.89  321.75  316.83  374.44  313.78  308.87Private and other payors 317.27  288.43  362.96  357.18  330.50  392.10  326.20  305.96Total skilled nursing revenue$431.71 $413.41 $464.31 $444.50 $425.26 $460.83 $435.10 $420.43  Six Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026 2025 2026 2025
 2026 2025 2026 2025SKILLED NURSING AVERAGE DAILY REVENUE RATESMedicare$812.17 $777.70 $885.86 $848.13 $796.67 $667.40 $822.04 $786.58Managed care 594.97  570.02  652.52  605.80  627.83  522.15  604.67  572.51Other skilled 646.93  645.85  680.76  668.45  659.88  714.24  651.51  650.67Total skilled revenue 682.14  657.16  773.10  739.60  714.40  621.17  697.78  667.17Medicaid 311.49  299.67  328.56  316.93  318.27  356.51  314.77  304.65Private and other payors 314.74  289.10  365.97  354.74  348.25  364.34  327.66  303.52Total skilled nursing revenue$431.75 $412.14 $465.42 $441.17 $434.75 $430.70 $436.73 $417.23 (1) The rates are based on contractually agreed-upon amounts or rates, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606.

The following tables set forth our percentage of skilled nursing patient revenue and days for the periods presented:

 Three Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026
 2025
 2026
 2025
 2026
 2025
 2026
 2025
                PERCENTAGE OF SKILLED NURSING REVENUEMedicare21.2% 20.9% 28.3% 27.8% 24.1% 19.1% 22.6% 21.9%Managed care19.6  19.9  15.1  14.0  14.4  13.0  18.2  18.6 Other skilled10.2  9.3  6.3  5.2  6.6  10.9  9.2  8.7 Skilled mix51.0% 50.1% 49.7% 47.0% 45.1% 43.0% 50.0% 49.2%Private and other payors7.1  6.9  8.4  9.2  10.6  10.0  7.7  7.5 Medicaid41.9  43.0  41.9  43.8  44.3  47.0  42.3  43.3 TOTAL SKILLED NURSING100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%  Three Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026
 2025
 2026
 2025
 2026
 2025
 2026
 2025
                PERCENTAGE OF SKILLED NURSING DAYSMedicare11.2% 11.1% 14.7% 14.5% 13.1% 12.6% 12.0% 11.6%Managed care14.1  14.3  10.6  10.2  9.7  10.8  13.0  13.5 Other skilled6.9  5.9  4.4  3.3  4.1  7.0  6.0  5.7 Skilled mix32.2% 31.3% 29.7% 28.0% 26.9% 30.4% 31.0% 30.8%Private and other payors9.6  9.9  10.7  11.5  13.7  11.8  10.4  10.2 Medicaid58.2  58.8  59.6  60.5  59.4  57.8  58.6  59.0 TOTAL SKILLED NURSING100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%  Six Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026
 2025
 2026
 2025
 2026
 2025
 2026
 2025
                PERCENTAGE OF SKILLED NURSING REVENUEMedicare21.4% 21.1% 28.4% 28.4% 25.2% 18.2% 23.0% 22.2%Managed care19.7  20.4  14.9  14.0  14.9  12.8  18.4  19.1 Other skilled10.0  9.1  6.4  5.2  6.7  8.9  8.9  8.4 Skilled mix51.1% 50.6% 49.7% 47.6% 46.8% 39.9% 50.3% 49.7%Private and other payors7.0  6.9  8.3  9.0  9.9  10.3  7.6  7.4 Medicaid41.9  42.5  42.0  43.4  43.3  49.8  42.1  42.9 TOTAL SKILLED NURSING100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%  Six Months Ended June 30, Same Facility Transitioning Acquisitions Total 2026
 2025
 2026
 2025
 2026
 2025
 2026
 2025
                PERCENTAGE OF SKILLED NURSING DAYSMedicare11.4% 11.2% 14.9% 14.8% 13.8% 11.8% 12.2% 11.8%Managed care14.3  14.7  10.6  10.2  10.4  10.5  13.3  13.9 Other skilled6.7  5.9  4.4  3.4  4.3  5.4  6.0  5.4 Skilled mix32.4% 31.8% 29.9% 28.4% 28.5% 27.7% 31.5% 31.1%Private and other payors9.5  9.8  10.6  11.2  12.4  12.2  10.0  10.1 Medicaid58.1  58.4  59.5  60.4  59.1  60.1  58.5  58.8 TOTAL SKILLED NURSING100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% THE ENSIGN GROUP, INC.
UNAUDITED REVENUE BY PAYOR SOURCE

The following tables set forth our service revenue by payor source and as a percentage of total service revenue for the periods presented:

 Three Months Ended June 30,  2026   2025  Revenue % of Revenue Revenue % of RevenueMedicaid(1)$566,819 39.6% $485,848 39.8%Medicare 339,650 23.7   291,117 23.8 Medicaid-skilled 80,664 5.6   75,207 6.2 Total Medicaid and Medicare$987,133 68.9% $852,172 69.8%Managed care 265,348 18.5   229,495 18.8 Private and other(2) 180,016 12.6   139,747 11.4 SERVICE REVENUE$1,432,497 100.0% $1,221,414 100.0% (1) Medicaid payor includes revenue for senior living operations.
(2) Private and other includes revenue for skilled services (private, Veteran Affairs and hospice payors), senior living and ancillary operations.

 Six Months Ended June 30,  2026   2025  Revenue % of Revenue Revenue % of RevenueMedicaid(1)$1,110,269 39.4% $939,688 39.3%Medicare 675,479 24.0   578,868 24.2 Medicaid-skilled 155,902 5.6   144,758 6.1 Total Medicaid and Medicare$1,941,650 69.0% $1,663,314 69.6%Managed care 526,199 18.7   456,712 19.1 Private and other(2) 346,951 12.3   268,428 11.3 SERVICE REVENUE$2,814,800 100.0% $2,388,454 100.0% (1) Medicaid payor includes revenue for senior living operations.
(2) Private and other includes revenue for skilled services (private, Veteran Affairs and hospice payors), senior living and ancillary operations.

THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION BY SEGMENT
(In thousands)

Skilled Services

The table below reconciles net income to EBITDA and Adjusted EBITDA for the skilled services reportable segment for the periods presented:

 Three Months Ended June 30, Six Months Ended June 30, 2026  2025  2026  2025 Statements of Income Data:       Segment income(1)$179,621 $150,004  $353,638 $293,935 Depreciation and amortization 15,445  13,750   30,755  26,963 EBITDA$195,066 $163,754  $384,393 $320,898 Adjustments to EBITDA:       Stock-based compensation expense 10,285  7,567   19,036  14,447 Gain on business interruption recoveries —  (1,000)  —  (1,000)ADJUSTED EBITDA$205,351 $170,321  $403,429 $334,345  (1) Segment income reflects profit from operations before provision for income taxes and impairment charges from operations. General and administrative expenses are not allocated to the skilled services segment for purposes of determining segment profit or loss.

Standard Bearer

The following table sets forth details of operating results for our revenue and earnings, and their respective components, by Standard Bearer for the periods presented:

 Three Months Ended June 30, Six Months Ended June 30,  2026  2025  2026  2025Rental revenue generated from third-party tenants$6,348 $4,712 $11,618 $9,209Rental revenue generated from Ensign's independent subsidiaries 37,785  26,756  68,617  50,660TOTAL RENTAL REVENUE$44,133 $31,468 $80,235 $59,869Segment income(1) 12,070  9,126  22,879  17,709Depreciation and amortization 12,676  9,265  23,459  17,741FFO(2)$24,746 $18,391 $46,338 $35,450 (1) Segment income reflects profit from operations before provision for income taxes, excluding gain or loss from sale of real estate, insurance recoveries and impairment of long-lived assets. Included in Standard Bearer expenses for the three and six months ended June 30, 2026 is management fee of $2.6 million and $4.8 million, respectively, and interest of $14.1 million and $23.9 million, respectively, from intercompany agreements between Standard Bearer and the Company and its independent subsidiaries, including the Service Center. Included in Standard Bearer expenses for the three and six months ended June 30, 2025 is management fee of $1.9 million and $3.6 million, respectively, and interest of $9.0 million and $16.1 million, respectively, from intercompany agreements between Standard Bearer and the Company and its independent subsidiaries, including the Service Center.

(2) FFO, in accordance with the definition used by the National Association of Real Estate Investment Trusts, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains or losses from sale of real estate, insurance recoveries related to real estate and impairment of long-lived assets, while including depreciation and amortization related to real estate to earnings.

Discussion of Non-GAAP Financial Measures

Adjusted EBT consists of net income before (a) provision for income taxes, (b) stock-based compensation expense, (c) acquisition related costs, (d) costs incurred related to system implementations, (e) loss (gain) on long-lived assets and business interruption recoveries, and (g) amortization of patient base intangible assets. Adjusted net income consists of net income excluding (a) stock‑based compensation expense, (b) acquisition related costs, (c) costs incurred related to system implementations, (d) loss (gain) on long-lived assets and business interruption recoveries, (e) amortization of patient base intangible assets and (f) the income tax effect of these adjustments. Adjusted earnings per share consists of adjusted net income divided by the weighted‑average diluted shares outstanding for the applicable period. EBITDA consists of net income before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization and (d) interest expense. Adjusted EBITDA consists of net income before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization, (d) interest expense, (e) stock-based compensation expense, (f) acquisition related costs, (g) costs incurred related to system implementations, and (h) loss (gain) on long-lived assets and business interruption recoveries. Adjusted EBITDAR consists of net income before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization, (d) interest expense, (e) rent-cost of services, (f) stock-based compensation expense, (g) acquisition related costs, (h) costs incurred related to system implementations, and (i) loss (gain) on long-lived assets and business interruption recoveries. Funds from Operations (FFO) for our Standard Bearer segment consists of segment income, excluding depreciation and amortization related to real estate, gains or losses from the sale of real estate, insurance recoveries related to real estate and impairment of long-lived assets. The Company believes that the presentation of adjusted EBT, adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA and FFO provides important supplemental information to management and investors to evaluate the Company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The Company believes disclosure of adjusted EBT, adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA, adjusted EBITDAR and FFO has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the Company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the Company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the Company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The Company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financials" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net. 

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System trimmed its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 7.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 134,667 shares of the company’s stock after selling 10,863 shares during the quarter. California Public Employees Retirement System owned 0.23% of The Ensign Group worth $27,135,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp increased its position in shares of The Ensign Group by 52.5% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 54,336 shares of the company’s stock valued at $9,465,000 after purchasing an additional 18,699 shares during the last quarter. Cypress Wealth Services LLC purchased a new position in shares of The Ensign Group in the 4th quarter worth about $1,508,000. SG Americas Securities LLC boosted its holdings in shares of The Ensign Group by 70.2% in the 4th quarter. SG Americas Securities LLC now owns 38,029 shares of the company’s stock worth $6,625,000 after buying an additional 15,683 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its position in The Ensign Group by 8.4% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 163,131 shares of the company’s stock valued at $28,417,000 after buying an additional 12,602 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in The Ensign Group by 14.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 129,756 shares of the company’s stock valued at $22,567,000 after buying an additional 16,853 shares during the period. 96.12% of the stock is currently owned by institutional investors.

Insider Activity In other news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the sale, the director owned 21,352 shares of the company’s stock, valued at $3,507,706.56. The trade was a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by company insiders.

Analysts Set New Price Targets A number of research firms recently issued reports on ENSG. Truist Financial decreased their price objective on shares of The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a report on Tuesday, July 14th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Weiss Ratings downgraded shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of The Ensign Group in a report on Tuesday, June 9th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $213.50.

Get Our Latest Report on ENSG

The Ensign Group Stock Down 0.7% ENSG stock opened at $170.87 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 27.83, a PEG ratio of 1.68 and a beta of 0.69. The Ensign Group, Inc. has a fifty-two week low of $134.79 and a fifty-two week high of $218.00. The stock has a fifty day moving average of $165.80 and a 200-day moving average of $184.01.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The business had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the previous year, the business posted $1.52 EPS. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, equities research analysts predict that The Ensign Group, Inc. will post 6.82 earnings per share for the current year.

The Ensign Group Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.065 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The Ensign Group’s dividend payout ratio (DPR) is presently 4.23%.

About The Ensign Group (Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Featured Articles Five stocks we like better than The Ensign Group Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG – Free Report).

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDimensional Fund Advisors LP Acquires 213,051 Shares of Aon plc $AON

NEXT HEADLINE »Dimensional Fund Advisors LP Acquires 834,885 Shares of Carnival Corporation $CCL

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the federal securities laws.

On June 8, 2026, Hunterbrook published a detailed short-seller report alleging that the company engaged in systemic quality-measure gaming, falsified care-quality data, and improper related-party billing across its skilled nursing operations. Following this news, the price of Ensign stock fell significantly, causing millions of dollars in shareholder losses.

Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act. This news caused the price of Ensign stock to drop even further.

“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said Andrea Farah, Lowey Dannenberg, P.C., Partner and Head of the firm’s securities practice.

If you suffered a loss in Ensign securities and wish to participate, check your eligibility through Lowey’s case management platform, https://claimmagic.com/cases/the-ensign-group. Alternatively, you can contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Attorney Advertising

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  [email protected]

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the federal securities laws.

On June 8, 2026, Hunterbrook published a detailed short-seller report alleging that the company engaged in systemic quality-measure gaming, falsified care-quality data, and improper related-party billing across its skilled nursing operations. Following this news, the price of Ensign stock fell significantly, causing millions of dollars in shareholder losses.

Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act. This news caused the price of Ensign stock to drop even further.

“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said Andrea Farah, Lowey Dannenberg, P.C., Partner and Head of the firm’s securities practice.

If you suffered a loss in Ensign securities and wish to participate, check your eligibility through Lowey’s case management platform, https://claimmagic.com/cases/the-ensign-group. Alternatively, you can contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Attorney Advertising

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email: [email protected]

SOURCE: Lowey Dannenberg

Key Takeaways ENSG added 22 operations in Q1 2026, bringing acquisitions to 71 since the start of 2025.ENSG same-store occupancy hit a record 84.3%, helping lift Q1 revenue 18.4% to $1.39 billion.ENSG ended Q1 with $539M in cash and an 8.12% trailing 12-month ROIC versus 3.05% for industry. The Ensign Group, Inc. (ENSG - Free Report) has built a successful growth strategy by acquiring underperforming skilled nursing and senior living facilities and improving their operations through local leadership and disciplined execution. Rather than pursuing acquisitions solely to expand its footprint, Ensign focuses on facilities where it sees opportunities to enhance occupancy, quality and profitability.

This strategy continued to deliver results in the first quarter of 2026. Ensign added 22 new operations during the quarter, bringing total acquisitions to 71 since the beginning of 2025. It has also been improving performance at existing facilities, with same-store occupancy reaching a record 84.3%. Driven by strong operational execution, first-quarter revenues increased 18.4% YOY to $1.39 billion, while adjusted earnings climbed to $1.85 per share.

Its trailing 12-month return on invested capital (ROIC) of 8.1% compared with the industry average of 3.1% also reflects efficient capital deployment.

Ensign's balance sheet remains a key advantage as it pursues additional acquisition opportunities. It ended the quarter with more than $539 million in cash and cash equivalents (up 7.1% from 2025-end) and $591.6 million available borrowing capacity,supporting its acquisition-driven growth strategy. Meanwhile, long-term debt, less current maturities, totaled only $136.5 million at first-quarter end.

These acquisitions should continue to support Ensign's long-term growth. As newly acquired facilities benefit from Ensign's operating model, occupancy levels and patient volumes can improve, driving higher revenues and earnings. The expanding portfolio also strengthens its's presence in existing and new markets. With a proven history of successfully turning around underperforming facilities, Ensign remains well positioned to benefit from future acquisitions.

How Are Competitors Faring?Ensign is not alone in using acquisitions to drive growth. Peers from the Medical space, such as The Pennant Group, Inc. (PNTG - Free Report) and Brookdale Senior Living Inc. (BKD - Free Report) , are also pursuing expansion strategies to strengthen their market positions.

Pennant Group, which was spun off from Ensign, continues to grow through acquisitions across its home health and hospice businesses. PNTG relies on a decentralized operating model, allowing local leaders to manage and improve acquired operations.

Brookdale Senior has focused on expanding and optimizing its senior housing portfolio. In 2025, BKD acquired 30 previously leased communities to increase its real estate ownership, while first-quarter 2026 occupancy improved to 82.1%, reflecting healthy demand and stronger operating performance.

ENSG’s Price Performance, Valuation & EstimatesShares of Ensign have gained 1% over the past year compared to the industry’s 4.9% growth over the same period.

Image Source: Zacks Investment Research

From a valuation standpoint, ENSG trades at a forward price-to-sales ratio of 1.48X, down from the industry average of 2.23X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ENSG’s 2026 earnings is pegged at $7.53 per share, implying a 14.6% jump from the year-ago period’s level.

Image Source: Zacks Investment Research

ENSG currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.